Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS MONTH'S ISSUE:
August 2014

Long-Acting Injectable Antipsychotics
The choice of whether or not to prescribe a long-acting injectable antipsychotic and, if so, which one to choose, should be based on the patient's ability to adhere to a oral medication regimen, individualized estimated risks and benefits, and cost.

Antidepressants and Suicidal Behavior: Effects of Dose and Age
For patients prescribed antidepressants, initiating treatment with higher doses may increase the risk of suicidal ideation and behavior in younger but not older patients.

In Brief
Girls with Anorexia Nervosa Have Increased Risk of Fractures; PTSD and Use of Antidepressants and Benzodiazepines during Pregnancy Increase Risk of Preterm Birth

Ramelteon (Rozerem)
Ramelteon (Rozerem) shows benefit for adults with insomnia in some trials, but the studies have been mostly short-term and the magnitude of difference compared with placebo has been small.

About the Editorial Advisory Committee

Editorial Advisory Committee:
Ross J. Baldessarini, M.D.
Joseph Biederman, M.D.
Rubin Bressler, M.D.
Andrew W. Brotman, M.D.
Ned Cassem, M.D.
Harold J. DeMonaco, M.S., R.Ph.
Susan R. Donaldson, M.D.
William E. Falk, M.D.
John Greist, M.D.
James W. Jefferson, M.D.
David Katzelnick, M.D.
Samuel J. Keith, M.D.
Martin B. Keller, M.D.
John Racy, M.D.
Eric M. Reiman, M.D.
Jerrold F. Rosenbaum, M.D.
A. John Rush, M.D.
Alan F. Schatzberg, M.D.
Nina R. Schooler, Ph.D.
Michael E. Thase, M.D.
Joanne Doller Wojcik, R.N., M.S.

Editor
Alan J. Gelenberg, M.D.

Assistant Editor
Heather S. Hopkins

Managing Editor
Amy Boynton